Izna Ali, PharmD
EDUCATION
Doctor of Philosophy, Pharmaceutical Sciences August 2014-Present
Division of Pharmacotherapy and Experimental Therapeutics (DPET)
University of North Carolina Eshelman School of Pharmacy Chapel Hill, NC
Doctor of Pharmacy May 2014
Magna Cum Laude
Chicago College of Pharmacy, Midwestern University
Pre-pharmacy 2008-2010
Benedictine University Lisle, IL
LICENSURES/CERTIFICATIONS
2012 Cardiopulmonary Resuscitation/ BLS
2012 APhA Pharmacy-Based Immunization Delivery
2012 Alzheimer’s Association Community Representative
2010 – Present HIPAA Certified Midwestern University
2009 – March 2015 Student Pharmacist, Illinois State Board of Pharmacy
PROFESSIONAL EXPERIENCE
Student Pharmacist February 2010-Present
Target Pharmacy Naperville, IL
Supervisor: Dr. Brian Moran, Pharm.D, Pharmacy Manager
• Receive new prescriptions via phone and interpret prescription orders from prescribers under the
supervision of the pharmacist.
• Process insurance claims and resolve issues
• Dispense medications and provide customer service
• Counsel patients on proper prescription and over the counter medication use with the pharmacist’s
supervision
Clinical Pharmacology Summer Intern Summer 2012
Takeda Pharmaceuticals Deerfield, IL
Supervisor: Dr. Ronald Lee, PhD, Associate Director
• Participated on project teams to provide guidance in the planning, management, and execution of clinical
pharmacology studies for clinical trials
• Collaborated with pharmacometrics, analytical science, clinical science, non-clinical science and CMC
functions on pharmacokinetic related information
• Verified clinical pharmacology data for accuracy on draft application prior to regulatory submission
• Provided reviews of clinical pharmacokinetics within documents such as synopsis, protocols, investigator
brochures, clinical study reports and investigational medicinal product dossier to ensure the scientific
integrity and quality
• Drafted the study synopsis for a food-effect study and the clinical pharmacology summary of a
bioavailability trial
• Proposed clinical trial design for drug-drug interaction study based on known genetic polymorphisms of
statins
• Investigated likely substrates that can be used to predict UGT mediated drug interactions
• Conducted literature analysis and designed a presentation about genetic polymorphisms of drug transporters
and glucuronidation to the Exploratory and Translational Development Department